[Results of administering Phlebodia 600 in fertile women with orthostasis-dependent phlebopathy].

Presented herein are the findings of a prospective, non-comparative study of the clinical efficacy of semisynthetic diosmine (preparation Phlebodia 600) in patients presenting withCEAP class 0-1 chronic venous insufficiency (CVI) manifesting itself as orthostasis-dependent phlebopathy. Based on a total of 67 case reports, it was shown that Phlebodia 600 exerted a positive effect on the functional symptoms of CVI, oedematic and convulsive syndromes. A conclusion was made of a high efficacy and safety of the drug in treatment of initial-grade CVI in fertile women with orthostasis-dependent phlebopathy, including hormone-induced variants. Noted was positive dynamics of the preparation with the necessity of continuing to take oral contraceptives by the medical indications.